New Jersey Governor Chris Christie, Ohio Governor John Kasich and U.S. Senator Rand Paul have made the field of 10 candidates who will participate in the next prime-time Republican presidential debate on Oct. 28, the debate’s host, CNBC, said on Wednesday.
The prime-time debate includes the top 10 candidates in opinion polls. The other seven candidates in the debate are front-runner Donald Trump, retired neurosurgeon Ben Carson, U.S. Senator Marco Rubio, former Florida Governor Jeb Bush, businesswoman Carly Fiorina, U.S. Senator Ted Cruz and former Arkansas Governor Mike Huckabee, the network said.
A separate debate several hours earlier for lower-polling candidates will comprise former U.S. Senator Rick Santorum, Louisiana Governor Bobby Jindal, former New York Governor George Pataki and U.S. Senator Lindsey Graham, CNBC said.
(Reporting by Eric Beech; Editing by Peter Cooney)
Democrats and Never-Trumpers gaming out ‘doomsday scenarios’ if president refuses to leave office: report
According to a report in the New York Times, Democratic strategists and Never-Trumper conservatives fear Donald Trump will refuse to leave office should he lose in November and are making plans and figuring out their legal options should such an unprecedented state of affairs come to pass.
The report, by the Times' Reid Epstein, begins with one such possible scenario.
‘Retaliation plain and simple’: Vaccine agency top Doc fired by Trump administration files whistleblower complaint
Dr. Rick Bright has retained an attorney and will be filing a whistleblower complaint after the Trump administration fired him from his position as head of the federal agency charged with developing a COVID-19 vaccine. Dr. Bright was moved to a different agency with a narrower focus after he raised concerns over President Donald Trump's obsession with promoting hydroxychloroquine, a malaria drug recent studies found doubles the death rate in coronavirus patients.
Checking blood for coronavirus antibodies – 3 questions answered about serological tests and immunity
Coronavirus testing in the United States is moving into a new phase as scientists begin looking into people’s blood for signs they’ve been infected by SARS-CoV-2, the virus that causes COVID-19. This technique is called serological testing.
Virologist Daniel Stadlbauer helped develop a serological test to detect SARS-CoV-2 antibodies and helped transfer it from the research lab to the clinical setting. Epidemiologist Aubree Gordon regularly uses serological assays in her research studies on influenza and dengue fever. She’s now established serological testing for SARS-CoV-2 in her research lab.